Assyro AI

FDA Orange Book · active-ingredient family

Amiloride hydrochloride

Amiloride hydrochloride is approved as 1 brand and 3 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:MIDAMOR · NDA 018200

1

Brand (NDA)

3

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · tablet

ProductApplicantApplicationTEApproved
MIDAMORRLDPADAGIS USNDA 018200ABApproved Prior to Jan 1, 1982

Generic (ANDA) products (3)

ProductApplicantApplicationTEApproved
AMILORIDE HYDROCHLORIDECHARTWELL RXANDA 204180Aug 07, 2015
AMILORIDE HYDROCHLORIDESIGMAPHARM LABS LLCANDA 079133ABJan 30, 2009
AMILORIDE HYDROCHLORIDEPH HEALTHANDA 070346ABJan 22, 1986

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Amiloride hydrochloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.